fda semaglutide compounding warning november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Counterfeit Ozempic Crackdown: Drugmakers Threaten

Fibroblast Migration and Early Tendon Repair (Chang et al., 2011) BPC-157 promoted fibroblast migration and protected cells from oxidative stress by activating the FAK-paxillin pathway

Microbiota plasticity in tilapia gut revealed by meta-analysis evaluating the effect of probiotics, prebiotics, and biofloc

Oncotarget 5 , 1266512674 (2014)

trial, making this a double layer of clinical validation: proven source + proven delivery method

Can Vital Blood be taken with blood pressure medication

Semaglutide Industry Leaders Novo Nordisk A/S *Disclaimer: Major Players sorted in no particular order Recent Industry Developments January 2026: Canada authorized a generic version of Ozempic, marking the first regulatory approval for a semaglutide follow-on in a significant market